February 9, 2009 - Implantation of drug-eluting stents to treat degenerative in aortocoronary saphenous vein graft ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
February 6, 2009 - Boston Scientific Corp. yesterday submitted to the FDA the final modules of the company’s pre ...
February 06, 2009
February 6, 2009 - Premier Purchasing Partners yesterday announced new agreements for drug-eluting coronary stents ...
February 06, 2009
February 3, 2009 – Medtronic has completed enrollment in PROTECT, the company’s global study comparing its ...
February 03, 2009
February 2, 2009 - Boston Scientific Corp. today said it began patient enrollment in the PLATINUM clinical trial ...
February 03, 2009
January 29, 2009 - Boston Scientific Corp. said today it received approval from the Japanese Ministry of Health ...
January 29, 2009January 28, 2009 - Data published this week in the online journal Circulation from the SPIRIT III U.S. pivotal ...
January 27, 2009January 28, 2009 - SurModics Inc. and Nexeon MedSystems Inc. this week signed a licensing agreement to collaborate on ...
January 27, 2009January 28, 2009 - Boston Scientific Corp. and Medtronic Inc. today announced the settlement of two lawsuits and an ...
January 27, 2009January 23, 2009 - Isotechnika Inc. said yesterday that partner Atrium Medical Corp. has completed patient enrollment ...
January 22, 2009January 13, 2009 - Micell Technologies, a development-stage biomedical device company dedicated to developing ...
January 12, 2009January 6, 2009 - Boston Scientific Corp. today said it acquired Labcoat Ltd., a privately held, development-stage drug ...
January 05, 2009December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size ...
December 17, 2008November 14, 2008 - A stent that entices artery-lining cells to coat it works as well, or better than, drug-eluting ...
November 13, 2008
November 13, 2008 - Medtronic Inc. today started its U.S. market launch of the Endeavor Sprint drug-eluting stent ...
November 12, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now